Diadexus Funding & Investors
South San Francisco, CA
Diadexus is a post-genomics company focused on translating raw genomics data into novel diagnostic and therapeutic products. The company develops these diagnostic and therapeutic products for improved detection, classification and prognosis of diseases.
diadexus.comTotal Amount Raised: $171,200,000
Diadexus Funding Rounds
Post Ipo Debt
$15,000,000
Post Ipo Debt Investors
Oxford FinancePost Ipo Debt
$4,500,000
Post Ipo Equity
$9,200,000
Post Ipo Equity Investors
Baker Bros. AdvisorsGSKScale Venture PartnersPost Ipo Equity
$40,000,000
Post Ipo Equity Investors
Baker Bros. AdvisorsScale Venture PartnersBurrill & CompanyMosaix VenturesBrookside CapitalGSKRho Capital PartnersPost Ipo Equity
$102,500,000
Post Ipo Equity Investors
BA Venture PartnersIPO
Unknown
Funding info provided by Diffbot.